Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 26/10/2020
SIETES contiene 93135 citas

 
 
 1 a 10 de 10 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Pal SN, Duncombe C, Falzon D, Olsson S. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf 2013;36:75-81. [Ref.ID 94862]
2.
Johansson K, Olsson S, Hellman B, Meyboom RHB. An analysis of Vigimed, a global e-mail system for the exchange of pharmacovigilance information. Drug Saf 2007;30:883-9. [Ref.ID 81226]
3.Tiene citas relacionadas Cita con resumen
Olsson S, Pal S. Drug bulletins: independent information for global use. Lancet 2006;368:903-4. [Ref.ID 77986]
4.
van Grrotheest K, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf 2004;13:457-64. [Ref.ID 70834]
5.
Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, De Freitas RM. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998;54:315-21. [Ref.ID 39267]
7.
Meyboom RHB, Olsson S, Knol A, Dekens-Konter JAM, De Koning GHP. Achilles tendinitis induced by pefloxacin and other fluoroquinolone derivatives. Pharmacoepidemiol Drug Saf 1994;3:185-9. [Ref.ID 23216]
8.
Olsson S, Edwards IR. Tachycardia during cisapride treatment. BMJ 1992;305:748-9. [Ref.ID 18092]
9.
Stricker BHCH, Slagboom G, Demaeseneer R, Slootmaekers V, Thijs I, Olsson S. Anaphylactic reactions to cinoxacin. BMJ 1988;297:1434-5. [Ref.ID 11998]
10.
Olsson S, Biriell C, Boman G. Photosensitivity during treatment with azapropazone. BMJ 1985;291:939. [Ref.ID 9249]
Seleccionar todas
 
 1 a 10 de 10